BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38510699)

  • 1. Quantitative susceptibility mapping for iron monitoring of multiple subcortical nuclei in type 2 diabetes mellitus: a systematic review and meta-analysis.
    Mohammadi S; Ghaderi S; Sayehmiri F; Fathi M
    Front Endocrinol (Lausanne); 2024; 15():1331831. PubMed ID: 38510699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron quantification in basal ganglia: quantitative susceptibility mapping as a potential biomarker for Alzheimer's disease - a systematic review and meta-analysis.
    Ghaderi S; Mohammadi S; Nezhad NJ; Karami S; Sayehmiri F
    Front Neurosci; 2024; 18():1338891. PubMed ID: 38469572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent changes in brain iron deposition and volume in deep gray matter nuclei using quantitative susceptibility mapping.
    Li G; Tong R; Zhang M; Gillen KM; Jiang W; Du Y; Wang Y; Li J
    Neuroimage; 2023 Apr; 269():119923. PubMed ID: 36739101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional high iron deposition on quantitative susceptibility mapping correlates with cognitive decline in type 2 diabetes mellitus.
    Hu R; Gao B; Tian S; Liu Y; Jiang Y; Li W; Li Y; Song Q; Wang W; Miao Y
    Front Neurosci; 2023; 17():1061156. PubMed ID: 36793541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating iron deposition in gray matter nuclei of patients with unilateral middle cerebral artery stenosis using quantitative susceptibility mapping.
    Mao H; Dou W; Chen K; Wang X; Wang X; Guo Y; Zhang C
    Neuroimage Clin; 2022; 34():103021. PubMed ID: 35500369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Brain Iron Deposition in the Putamen in Patients with Type 2 Diabetes Mellitus Detected by Quantitative Susceptibility Mapping.
    Li J; Zhang Q; Zhang N; Guo L
    J Diabetes Res; 2020; 2020():7242530. PubMed ID: 33062715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain iron deposition in type 2 diabetes mellitus with and without mild cognitive impairment-an in vivo susceptibility mapping study.
    Yang Q; Zhou L; Liu C; Liu D; Zhang Y; Li C; Shang Y; Wei X; Li C; Wang J
    Brain Imaging Behav; 2018 Oct; 12(5):1479-1487. PubMed ID: 29297155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative susceptibility mapping in multiple sclerosis: A systematic review and meta-analysis.
    Voon CC; Wiltgen T; Wiestler B; Schlaeger S; Mühlau M
    Neuroimage Clin; 2024; 42():103598. PubMed ID: 38582068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative susceptibility mapping in amyotrophic lateral sclerosis: automatic quantification of the magnetic susceptibility in the subcortical nuclei.
    Ghaderi S; Fatehi F; Kalra S; Mohammadi S; Batouli SAH
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 Jul; ():1-12. PubMed ID: 38957123
    [No Abstract]   [Full Text] [Related]  

  • 10. Spatiotemporal variations of magnetic susceptibility in the deep gray matter nuclei from 1 month to 6 years: A quantitative susceptibility mapping study.
    Ning N; Liu C; Wu P; Hu Y; Zhang W; Zhang L; Li M; Gho SM; Kim DH; Guo H; Yang J; Jin C
    J Magn Reson Imaging; 2019 Jun; 49(6):1600-1609. PubMed ID: 30569483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain iron assessment in patients with First-episode schizophrenia using quantitative susceptibility mapping.
    Xu M; Guo Y; Cheng J; Xue K; Yang M; Song X; Feng Y; Cheng J
    Neuroimage Clin; 2021; 31():102736. PubMed ID: 34186296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron Deposition Characteristics of Deep Gray Matter in Elderly Individuals in the Community Revealed by Quantitative Susceptibility Mapping and Multiple Factor Analysis.
    Li J; Zhang Q; Che Y; Zhang N; Guo L
    Front Aging Neurosci; 2021; 13():611891. PubMed ID: 33935681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
    Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
    Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reproducibility analysis of quantitative susceptibility mapping of cerebral subcortical nuclei in healthy adults].
    Xu H; Meng Q; Fan W; Wang X; Liu M; Chen Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Dec; 40(12):1810-1815. PubMed ID: 33380400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatiotemporal patterns of brain iron-oxygen metabolism in patients with Parkinson's disease.
    Yan S; Lu J; Li Y; Cho J; Zhang S; Zhu W; Wang Y
    Eur Radiol; 2024 May; 34(5):3074-3083. PubMed ID: 37853173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-atlas tool for automated segmentation of brain gray matter nuclei and quantification of their magnetic susceptibility.
    Li X; Chen L; Kutten K; Ceritoglu C; Li Y; Kang N; Hsu JT; Qiao Y; Wei H; Liu C; Miller MI; Mori S; Yousem DM; van Zijl PCM; Faria AV
    Neuroimage; 2019 May; 191():337-349. PubMed ID: 30738207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep grey matter iron accumulation in alcohol use disorder.
    Juhás M; Sun H; Brown MRG; MacKay MB; Mann KF; Sommer WH; Wilman AH; Dursun SM; Greenshaw AJ
    Neuroimage; 2017 Mar; 148():115-122. PubMed ID: 28065850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping.
    Shahmaei V; Faeghi F; Mohammdbeigi A; Hashemi H; Ashrafi F
    Eur J Radiol Open; 2019; 6():169-174. PubMed ID: 31065578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron quantification in basal ganglia using quantitative susceptibility mapping in a patient with ALS: a case report and literature review.
    Ghaderi S; Batouli SAH; Mohammadi S; Fatehi F
    Front Neurosci; 2023; 17():1229082. PubMed ID: 37877011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.